AI assistant
Sending…
Invivyd, Inc. — Director's Dealing 2021
Nov 2, 2021
33564_dirs_2021-11-02_3c505242-552a-43f0-9925-b488cc3db5a3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Adagio Therapeutics, Inc. (ADGI)
CIK: 0001832038
Period of Report: 2021-11-01
Reporting Person: Andersen Jill (Chief Legal Officer, Secretary)
More from Invivyd, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Share Issue/Capital Change
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Investor Presentation
2026
Apr 9
Annual Report
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19